Excalibur Management’s Colgate-Palmolive CL Stock Holding History

Excalibur Management’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$218K	Sell	2,383 -7	-0.3%	-$612	0.07%	162
2026 Q1	$204K	Buy	+2,390	New	+$213K	0.07%	155
2025 Q4	–	Sell	-2,520	Closed	-$201K	–	163
2025 Q3	$201K	Hold	2,520	–	–	0.07%	161
2025 Q2	$229K	Sell	2,520 -10	-0.4%	-$913	0.09%	154
2025 Q1	$237K	Hold	2,530	–	–	0.09%	149
2024 Q4	$230K	Sell	2,530 -25	-1%	-$2.39K	0.09%	152
2024 Q3	$265K	Sell	2,555 -50	-2%	-$5.1K	0.1%	145
2024 Q2	$253K	Sell	2,605 -50	-2%	-$4.61K	0.1%	143
2024 Q1	$239K	Buy	2,655 +40	+2%	+$3.39K	0.1%	144
2023 Q4	$208K	Buy	+2,615	New	+$197K	0.1%	150
2022 Q3	–	Sell	-2,560	Closed	-$205K	–	151
2022 Q2	$205K	Buy	+2,560	New	+$200K	0.11%	142
2022 Q1	–	Sell	-2,678	Closed	-$229K	–	156
2021 Q4	$229K	Hold	2,678	–	–	0.09%	148
2021 Q3	$202K	Hold	2,678	–	–	0.09%	151
2021 Q2	$218K	Buy	2,678 +38	+1%	+$3.11K	0.1%	149
2021 Q1	$208K	Sell	2,640 -25	-0.9%	-$1.96K	0.1%	145
2020 Q4	$228K	Sell	2,665 -25	-0.9%	-$2.07K	0.12%	132
2020 Q3	$208K	Buy	+2,690	New	+$205K	0.13%	122

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Excalibur Management's CL Position: Q2 2026 in Review

Excalibur Management reduced its Colgate-Palmolive (CL) stake by 0.29% in Q2 2026, selling an estimated $612 and leaving 2,383 shares worth $218K. The position accounts for 0.07% of the portfolio, ranked #162.

Excalibur Management first reported a position in CL in Q3 2020 and has held it in 17 quarters since. The position peaked at $265K in Q3 2024. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Excalibur Management held 2,383 shares of Colgate-Palmolive worth $218K as of Q2 2026.
Excalibur Management sold 7 Colgate-Palmolive shares in Q2 2026, an estimated $612.
Colgate-Palmolive made up 0.07% of Excalibur Management's portfolio in Q2 2026, its #162 holding.
Excalibur Management first reported a position in Colgate-Palmolive in Q3 2020 and has held it in 17 quarters since.
Excalibur Management's Colgate-Palmolive position peaked at $265K in Q3 2024.
2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Excalibur Management's 13F filing for Q2 2026, filed 3 Aug 2026.